International Journal of Nephrology最新文献

筛选
英文 中文
Zinc Acetate Hydrate Supplementation versus Polaprezinc Supplementation for Improving Hypozincemia in Hemodialysis Patients: A Randomized Clinical Trial. 补充醋酸锌水合物与补充安定改善血液透析患者低锌血症的随机临床试验。
IF 2.1
International Journal of Nephrology Pub Date : 2023-10-05 eCollection Date: 2023-01-01 DOI: 10.1155/2023/2403755
Etsuko Kumagai, Kazuhiro Furumachi, Akihiro Kurihara, Ken Hosokawa, Keiko Hosohata, Shinji Takai
{"title":"Zinc Acetate Hydrate Supplementation versus Polaprezinc Supplementation for Improving Hypozincemia in Hemodialysis Patients: A Randomized Clinical Trial.","authors":"Etsuko Kumagai,&nbsp;Kazuhiro Furumachi,&nbsp;Akihiro Kurihara,&nbsp;Ken Hosokawa,&nbsp;Keiko Hosohata,&nbsp;Shinji Takai","doi":"10.1155/2023/2403755","DOIUrl":"10.1155/2023/2403755","url":null,"abstract":"<p><p>Zinc supplementation may ameliorate zinc deficiency in maintenance hemodialysis patients; however, no standard protocol has been established. This study aimed to investigate the effects of zinc acetate hydrate (ZAH) and polaprezinc (PPZ) as zinc supplements in hemodialysis patients. We enrolled 75 hemodialysis patients with serum zinc levels <60 <i>μ</i>g/dL for this study and randomly assigned Zinc supplementation to these 75 patients: 37 received ZAH (50 mg/day), and 38 received PPZ (34 mg/day). Serum zinc levels of both groups were compared every 4 weeks for 1 year. In both groups, serum zinc levels significantly increased at 4-52 weeks. Serum zinc levels were significantly higher in the ZAH group at 4-12 weeks; however, no significant differences were observed between the groups at 16-52 weeks. Adverse events requiring a reduction in the zinc dose, including copper deficiency, occurred significantly more frequently in the ZAH group. In conclusion, PPZ can safely maintain serum zinc levels for 1 year. ZAH provides rapid zinc supplementation but can cause adverse events.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569889/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41235113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunophenotypic Characterization of Citrate-Containing A Concentrates in Maintenance Hemodialysis: A Pre-Post Study. 维持性血液透析中含柠檬酸A浓缩物的免疫表型特征:一项前后研究。
IF 2.1
International Journal of Nephrology Pub Date : 2023-09-27 eCollection Date: 2023-01-01 DOI: 10.1155/2023/7772677
Yuli Shen, Christoph Schmaderer, Andreas Ossadnik, Arianne Hammitzsch, Javier Carbajo-Lozoya, Quirin Bachmann, Vera Bonell, Matthias Christoph Braunisch, Uwe Heemann, Dang Pham, Stephan Kemmner, Georg Lorenz
{"title":"Immunophenotypic Characterization of Citrate-Containing A Concentrates in Maintenance Hemodialysis: A Pre-Post Study.","authors":"Yuli Shen,&nbsp;Christoph Schmaderer,&nbsp;Andreas Ossadnik,&nbsp;Arianne Hammitzsch,&nbsp;Javier Carbajo-Lozoya,&nbsp;Quirin Bachmann,&nbsp;Vera Bonell,&nbsp;Matthias Christoph Braunisch,&nbsp;Uwe Heemann,&nbsp;Dang Pham,&nbsp;Stephan Kemmner,&nbsp;Georg Lorenz","doi":"10.1155/2023/7772677","DOIUrl":"10.1155/2023/7772677","url":null,"abstract":"<p><strong>Introduction: </strong>Due to chronic inflammation, maintenance hemodialysis (MHD) patients continue to show excess mortality. Acetate-free citrate-buffered A concentrates could be a way to improve the biocompatibility of the procedure, reduce chronic inflammation, and thus in the long term improve the prognosis of patients.</p><p><strong>Methods: </strong>Using a pre-post design (3 months of acetate followed by 3 months of citrate-acidified A concentrates in standard bicarbonate-based dialysate hemodialysis, CiaHD) and linear mixed model analysis in 61 stable HD patients, we assessed the impact of CiaHD on counts and phenotypes of peripheral T cells and monocytes by flow cytometry.</p><p><strong>Results: </strong>Switching to CiaHD left C-reactive protein (CRP) levels and leucocyte counts unaffected. However, CiaHD increased lymphocyte counts ex vivo. Furthermore, we found a decrease in total CD3+CD4+CD69+ ((10<sup>9</sup>/L), mean ± SD: acetate, 0.04 ± 1.0 versus citrate, 0.02 ± 0.01; <i>P</i> = 0.02) activated cells, while the number of CD28+ T cells remained stable. No differences were noted regarding T-cell exhaustion marker expression, CD14+CD16+ monocyte counts, and PMN-MDSCs.</p><p><strong>Conclusion: </strong>Compared with acetate, CiaHD has a minor impact on lymphocyte counts and CD4+T-cell activation, which was independent of systemic CRP and ionized magnesium, calcium levels, and other dialysis prescription modalities.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551471/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41126883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Three Glomerular Filtration Rate Estimating Equations with 24-Hour Urine Creatinine Clearance Measurement in Potential Living Kidney Donors. 三种肾小球滤过率估算公式与 24 小时尿液肌酐清除率测量在潜在活体肾脏捐献者中的比较
IF 1.7
International Journal of Nephrology Pub Date : 2023-06-15 eCollection Date: 2023-01-01 DOI: 10.1155/2023/2022641
Fernando Giron-Luque, Andrea Garcia-Lopez, Yenny Baez-Suarez, Nasly Patino-Jaramillo
{"title":"Comparison of Three Glomerular Filtration Rate Estimating Equations with 24-Hour Urine Creatinine Clearance Measurement in Potential Living Kidney Donors.","authors":"Fernando Giron-Luque, Andrea Garcia-Lopez, Yenny Baez-Suarez, Nasly Patino-Jaramillo","doi":"10.1155/2023/2022641","DOIUrl":"10.1155/2023/2022641","url":null,"abstract":"<p><strong>Background: </strong>The accuracy of the measurement of renal function in potential living kidney donors (PLKD) is essential. The direct measurement of glomerular filtration rate (mGFR) has been considered the \"gold standard.\" The estimated GFR (eGFR) with 24-hour urinary creatinine clearance (CrCl) is frequently used because of its availability. We aim to evaluate the correlation and agreement of eGFR using serum-based creatinine formulas (Cockcroft-Gault, MDRD, and CKD-EPI) and the eGFR based on 24-hour urinary CrCl to evaluate kidney function in PLKD.</p><p><strong>Methods: </strong>We evaluated the kidney function in 799 PLKD using 24-hour urinary CrCl method and compared the correlation and agreement with the eGFR based on creatinine formulas (Cockcroft-Gault, MDRD, and CKD-EPI). We calculated the mean bias (difference), precision (SD of this difference), accuracy, and performed Bland-Altman plots.</p><p><strong>Results: </strong>A total of 799 PLKD were analyzed. The age of the PLKD ranged from 18 to 73 years. Weak to mild correlation was observed between 24-hour urinary CrCl and all formulas (ranged from 0.31 to 0.49). The three equations underestimated the GFR. Using the Bland-Altman graphic, we observed that the CKD-EPI was the least scattered and most precise; however, mean bias and the interval range (limits of agreement) of all formulas were too big to assume equivalence between 24-hour urinary CrCl method and eGFR based on creatinine. Results of mean bias were similar when comparing the three equations in patients with CrCl GFR <60. However, the accuracy of all formulas was better for the female group and the youngest individuals (≤40 years old).</p><p><strong>Conclusion: </strong>In this PLKD cohort, of all the three equations, the CKD-EPI was the least scattered and most precise. However, the correlation and the level of agreement between the three equations and 24-hour urinary CrCl were too low to assume the equivalence.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10094973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Magnetic Resonance Visibility, Artifacts, and Overall Safety of the Self-Locating Peritoneal Dialysis Catheter with a Tungsten Tip. 带钨尖头的自定位腹膜透析导管的磁共振可见度、伪影和总体安全性。
IF 1.7
International Journal of Nephrology Pub Date : 2023-01-24 eCollection Date: 2023-01-01 DOI: 10.1155/2023/7901413
Maurizio Gallieni, Umberto G Rossi, Massimo Tonolini, Andrea Ianniello, Roberta Miglio, Gianmarco Sabiu, Maurizio Cariati
{"title":"Magnetic Resonance Visibility, Artifacts, and Overall Safety of the Self-Locating Peritoneal Dialysis Catheter with a Tungsten Tip.","authors":"Maurizio Gallieni, Umberto G Rossi, Massimo Tonolini, Andrea Ianniello, Roberta Miglio, Gianmarco Sabiu, Maurizio Cariati","doi":"10.1155/2023/7901413","DOIUrl":"10.1155/2023/7901413","url":null,"abstract":"<p><strong>Background: </strong>The self-locating peritoneal dialysis (PD) catheter, contains a tungsten tip. The effects of magnetic resonance (MR) on the catheter were evaluated, emphasizing its MR signal, artifacts, ferromagnetism, and possible heating production during the MR sequences.</p><p><strong>Methods: </strong>The catheter was studied in an ex vivo model using a 1.5T MR system and placed into a plastic box containing saline solution. Acquisitions on coronal and axial planes were obtained on fast gradient-echo T1-weighted and fast spin-echo T2-weighted. In vivo abdominal MR exams were also carried out.</p><p><strong>Results: </strong>Overall, the catheter had good visibility. In all sequences, an extensive paramagnetic blooming artifact was detected at the level of the tip tungsten ballast, with a circular artifact of 5 cm in diameter. The catheter showed no magnetic deflection, rotation, or movements during all MR sequences. After imaging, the temperature of the saline solution did not change compared to the basal measurement. Patients safely underwent abdominal MR.</p><p><strong>Conclusions: </strong>The results point to the possibility of safely performing MR in PD patients carrying the self-locating catheter. The self-locating PD catheter is stable when subjected to a 1.5T MR system. However, it creates some visual interference, preventing an accurate study of the tissues surrounding the tungsten tip.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9198011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Bedside Removal of Tunnelled Hemodialysis Catheter by Noninterventional Nephrologists among Adult Patients in the King Abdulaziz University Hospital Hemodialysis Centre in Jeddah: A Retrospective Cohort Study. 吉达阿卜杜勒阿齐兹国王大学医院血液透析中心非介入性肾脏科医师床边取出隧道式血液透析导管的有效性和安全性:一项回顾性队列研究
IF 2.1
International Journal of Nephrology Pub Date : 2023-01-01 DOI: 10.1155/2023/6905528
Abdullah Kashgary, Razan A Almuhyawi, Reem R Alhijri, Aseel M Ba Durayq, Wed B Alnagrani, Arwa J Alharbi, Hamidah M Al Khalaf, Haya S Obaid, Ahmed Zaky Fadel, Mostafa Abdelsalam
{"title":"Efficacy and Safety of Bedside Removal of Tunnelled Hemodialysis Catheter by Noninterventional Nephrologists among Adult Patients in the King Abdulaziz University Hospital Hemodialysis Centre in Jeddah: A Retrospective Cohort Study.","authors":"Abdullah Kashgary,&nbsp;Razan A Almuhyawi,&nbsp;Reem R Alhijri,&nbsp;Aseel M Ba Durayq,&nbsp;Wed B Alnagrani,&nbsp;Arwa J Alharbi,&nbsp;Hamidah M Al Khalaf,&nbsp;Haya S Obaid,&nbsp;Ahmed Zaky Fadel,&nbsp;Mostafa Abdelsalam","doi":"10.1155/2023/6905528","DOIUrl":"https://doi.org/10.1155/2023/6905528","url":null,"abstract":"<p><p>This study aimed to assess the efficacy and safety of bedside removal of tunnelled hemodialysis catheter (TDC) by noninterventional nephrologists among adult patients. It is a retrospective study that involved 53 patients from March 2020 to February 2022 at the King Abdulaziz University Hospital (KAUH) Hemodialysis Centre in Jeddah, Saudi Arabia. Of the 53 participants, 60.4% were male and 40.6% female, and their mean age was 50.94 ± 18.89 years. The most common comorbidities were hypertension (HTN) in 47 (88.7%), diabetes mellitus (DM) in 24 (45.3%), and DM and HTN together in 23 (43.4%) patients. The most common site of TDC removal was the right internal jugular vein (77.4%). In 84.9% of the cases, the TDC was removed as an inpatient procedure, and in the majority of the cases (64.2%), the TDC was removed by a noninterventional nephrologist. The most common reasons for TDC removal were sepsis or clinical concerns for infection (64.2%) and TDC not needed (20.8%) due to recovery of the renal function or access maturation. Most patients (96.2%) suffered no complications; only one of 34 (%) patients with catheter removal by a noninterventional nephrologist had bleeding, which required more observation and monitoring before discharge on the same day. Our study revealed that the bedside TDC removal was well tolerated with a minimal complication rate.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9626487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Growth Differentiation Factor 15 and Risk of Death in Haemodialysis Patients. 生长分化因子15与血液透析患者死亡风险的关系
IF 2.1
International Journal of Nephrology Pub Date : 2023-01-01 DOI: 10.1155/2023/5163548
Christelle Calen, Seraina Von Moos, Pietro Cippà, Alexandre Mebazaa, Mattia Arrigo
{"title":"Growth Differentiation Factor 15 and Risk of Death in Haemodialysis Patients.","authors":"Christelle Calen,&nbsp;Seraina Von Moos,&nbsp;Pietro Cippà,&nbsp;Alexandre Mebazaa,&nbsp;Mattia Arrigo","doi":"10.1155/2023/5163548","DOIUrl":"https://doi.org/10.1155/2023/5163548","url":null,"abstract":"<p><strong>Aim: </strong>Noninvasive identification of haemodialysis patients at high risk of cardiovascular events and death might improve their outcome. Growth differentiation factor 15 is a prognostic biomarker in multiple disease entities, including cardiovascular disease. The aim of this study was to assess the association between plasma GDF-15 and mortality in a cohort of haemodialysis patients.</p><p><strong>Methods: </strong>Circulating GDF-15 was measured in 30 patients after a regular haemodialysis session, followed by a clinical follow-up for all-cause death. Measurements were performed using the Proseek Multiplex Cardiovascular disease panels (Olink Proteomics AB) and validated using the Elecsys GDF-15 electrochemiluminescence immunoassay on a Cobas E801 analyzer (Roche Diagnostics).</p><p><strong>Results: </strong>During a median of 38 months, 9 patients (30%) died. Seven deaths occurred in the group of patients with a circulating GDF-15 above the median and two in the group with lower GDF-15. Mortality was significantly higher in patients with circulating GDF-15 levels above the median, log-rank<i>P</i> = 0.044. The performance of circulating GDF-15 to predict long-term mortality has an area under the ROC curve of 0.76, <i>P</i> = 0.028. Prevalence of most relevant comorbidities and the Charlson comorbidity index were similar across the two groups. A high agreement with a correlation among both diagnostic methods was observed (Spearman's rho = 0.83, <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Plasma GDF-15 displays promising prognostic properties for the prediction of long-term survival beyond clinical parameters in patients on maintenance haemodialysis.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9611062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Hyperoxaluria Type 1: Clinical, Paraclinical, and Evolutionary Aspects in Adults from One Nephrology Center. 原发性高草酸尿1型:成人的临床、临床旁和进化方面
IF 2.1
International Journal of Nephrology Pub Date : 2023-01-01 DOI: 10.1155/2023/2874414
Hajji Meriam, Asma Bettaieb, Hayet Kaaroud, Fethi Ben Hamida, Taher Gargeh, Ridha Mrad, Kahena Bouzid, Ezzeddine Abderrahim
{"title":"Primary Hyperoxaluria Type 1: Clinical, Paraclinical, and Evolutionary Aspects in Adults from One Nephrology Center.","authors":"Hajji Meriam,&nbsp;Asma Bettaieb,&nbsp;Hayet Kaaroud,&nbsp;Fethi Ben Hamida,&nbsp;Taher Gargeh,&nbsp;Ridha Mrad,&nbsp;Kahena Bouzid,&nbsp;Ezzeddine Abderrahim","doi":"10.1155/2023/2874414","DOIUrl":"https://doi.org/10.1155/2023/2874414","url":null,"abstract":"<p><strong>Introduction: </strong>Primary hyperoxaluria type 1 (PH1) is a rare and inherited condition of urolithiasis. The aim of our study was to analyze clinical, paraclinical, and evolutionary aspects of PH1 in adult patients in our Nephrology department.</p><p><strong>Methods: </strong>We conducted a retrospective single-center study between 1990 and 2021. We collected patients followed for PH1 confirmed by genetic study and/or histopathological features of renal biopsy and morphoconstitutional analysis of the calculi.</p><p><strong>Results: </strong>There were 25 patients with a gender ratio of 1.78. The median age at onset of symptoms was 18 years. A delay in diagnosis more than 10 years was noted in 13 cases. The genetic study found the I244T mutation in 17 cases and 33-34 InsC in 4 cases. A kidney biopsy was performed in 5 cases, on a native kidney in 4 cases and on a graft biopsy in one case. The analysis of calculi was done in 10 cases showing type Ic in 2 cases. After a median follow-up of 13 years (1 year-42 years), 14 patients progressed to end-stage chronic renal failure (ESRD). The univariate study demonstrated a remarkable association with progression to ESRD in our population (44% vs. 56%) RR = 13.32 (adjusted ORs (95% CI): 2.82-62.79) (<i>p</i> < 0.01).</p><p><strong>Conclusion: </strong>Progression to ESRD was frequent in our series. Early diagnosis and adequate management can delay such an evolution.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372328/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9900994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Blind Spot in the Radar of MEST-C Score: Type and Severity of Tubulointerstitial Nephritis in IgA Nephropathy. MEST-C评分的盲点:IgA肾病小管间质性肾炎的类型和严重程度。
IF 2.1
International Journal of Nephrology Pub Date : 2023-01-01 DOI: 10.1155/2023/1060526
Iram Asrar, Mudassar Hussain, Aurangzeb Afzal, Usman Hassan, Sheeba Ishtiaq
{"title":"Blind Spot in the Radar of MEST-C Score: Type and Severity of Tubulointerstitial Nephritis in IgA Nephropathy.","authors":"Iram Asrar,&nbsp;Mudassar Hussain,&nbsp;Aurangzeb Afzal,&nbsp;Usman Hassan,&nbsp;Sheeba Ishtiaq","doi":"10.1155/2023/1060526","DOIUrl":"https://doi.org/10.1155/2023/1060526","url":null,"abstract":"<p><strong>Background: </strong>The updated version of predictive classification for immunoglobulin A nephropathy (IgAN) prognosis \"The Oxford Classification\" identifies five histopathological features including mesangial hypercellularity (M), endocapillary proliferation (E), segmental glomerulosclerosis (S), tubular atrophy/interstitial fibrosis (T) and crescents (C), the MEST-C. However, few studies suggest that tubulointerstitial inflammation, which is not included in the MEST-C, is also linked to disease progression and is, consequently, a neglected determinant of prognosis among others. Therefore, there is a need to evaluate this histopathological parameter in patients with IgA nephropathy.</p><p><strong>Materials and methods: </strong>This cross-sectional descriptive study was conducted at Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan. Data of histopathological and immunofluorescence proven renal biopsies (300) of IgA nephropathy patients from January 2016 through May 2022 were extracted using a convenient sampling technique. Biopsies were histologically reviewed for type and severity of tubulointerstitial inflammation, in addition to the MEST-C score. Renal biopsies of patients who had a history of transplant, autolyzed tissue, no glomeruli on histological examination, and/or a tubular atrophy/interstitial fibrosis score of 2 (T2) in MEST-C scoring were excluded. Data were analyzed using SPSS 20. An association between the variables was analyzed using the chi-square and Fischer exact tests. A <i>p</i> value less than 0.05 was considered statistically significant.</p><p><strong>Results: </strong>A total of 247/300 biopsies were eligible for inclusion. The mean age at the time of biopsy was 31.90 ± 12.48 with 63.6% in the age group between 21 and 40 years, and 69.6% were male. Tubulointerstitial inflammation was observed in 90.2% cases with 49.4% showing moderate while 4.5% showing severe degree of inflammation. A strong association of both the type and severity of tubulointerstitial inflammation was found with M, E, T, and C scores (<i>p</i> value < 0.05).</p><p><strong>Conclusion: </strong>The high-frequency and strong statistical association of tubulointerstitial inflammation with the M, E, T, and C scores in our study elucidate its prognostic role in the progression and management of IgA nephropathy.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027444/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9167022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effects of Oral Sodium Bicarbonate Supplementation on Protein Metabolism and Inflammation in Iraqi Hemodialysis Patients: An Open-Label Randomized Controlled Trial. 口服碳酸氢钠对伊拉克血液透析患者蛋白质代谢和炎症的影响:一项开放标签随机对照试验。
IF 2.1
International Journal of Nephrology Pub Date : 2023-01-01 DOI: 10.1155/2023/6657188
Zina A Rasheed, Ban A Al-Hashemi, Ala A Ali
{"title":"Effects of Oral Sodium Bicarbonate Supplementation on Protein Metabolism and Inflammation in Iraqi Hemodialysis Patients: An Open-Label Randomized Controlled Trial.","authors":"Zina A Rasheed,&nbsp;Ban A Al-Hashemi,&nbsp;Ala A Ali","doi":"10.1155/2023/6657188","DOIUrl":"https://doi.org/10.1155/2023/6657188","url":null,"abstract":"<p><strong>Background: </strong>The effect of correcting metabolic acidosis on protein metabolism in hemodialysis patients is controversial.</p><p><strong>Objectives: </strong>To study the effects of oral sodium bicarbonate on protein metabolism and markers of inflammation in acidotic hemodialysis patients. <i>Patients and Methods</i>. An open-label randomized controlled trial was conducted at a single center. Sixty-six clinically stable adult hemodialysis patients were recruited with an average predialysis serum bicarbonate level of <22 mmol/l and a dialysate bicarbonate concentration of 35 mmol/l. Forty-nine participants have completed the study. Oral sodium bicarbonate tablets of 500 mg were given daily in the intervention group (<i>n</i> = 25) for 12 weeks versus the standard of care in the control group (<i>n</i> = 24). Outcomes compared intervention versus nonintervention in both groups at equivalent time points (0 and 3 months). The clinical data, anthropometry, dialysis adequacy, albumin, normalized protein catabolism rate, blood gas analysis, and bicarbonate were recorded at 0 and 3 months. In addition, muscle mass and handgrip strength were measured. Finally, IL-6 as a marker of inflammation was measured at randomization and three months.</p><p><strong>Results: </strong>Serum bicarbonate and pH increased significantly from 17.57 ± 3.34 mmol/L to 20.69 ± 2.54 mmol/L and from 7.26 ± 0.06 to 7.34 ± 0.04, respectively (<i>p</i> < 0.0001). Serum albumin was significantly higher in the intervention group at three months than in the control group, 4.11 ± 0.45 vs. 3.79 ± 0.47 (<i>p</i> value 0.011). Serum potassium significantly decreased in the intervention group at three months compared to the control group, 5.00 ± 0.43 mEq/l vs. 5.33 ± 0.63 mEq/l (<i>p</i> value 0.03). Muscle strength expressed as handgrip has improved significantly in the intervention group at three months compared to the control group, 45.01 ± 19.19 vs. 33.93 ± 15.06 (<i>p</i> value 0.03). The IL-6 values were less in the intervention group at 3 months with a <i>p</i> value of 0.01. The interdialytic weight of the intervention group at three months was 2.42 ± 0.64 compared to the 2.20 ± 1.14 control group, but this did not reach statistical significance (<i>p</i> value of 0.4). The composite of (albumin + nPCR) at three months was achieved in 59.18% of the intervention group compared to 14.28% with a <i>p</i> value of 0.01.</p><p><strong>Conclusions: </strong>Correcting metabolic acidosis in hemodialysis patients improved serum albumin and nPCR without hypokalemia or significant interdialytic weight gain. This was particularly evident in patients with minimal inflammation with low IL-6 values.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403331/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9943351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Somatic Symptoms of Depression Lose Association with Mortality upon Adjustment for Frailty: Analysis from the Fitness Haemodialysis Cohort. 虚弱调整后抑郁的躯体症状丧失与死亡率的关联:来自健康血液透析队列的分析
IF 2.1
International Journal of Nephrology Pub Date : 2023-01-01 DOI: 10.1155/2023/4518843
Benjamin M Anderson, Muhammad Qasim, Gonzalo Correa, Felicity Evison, Suzy Gallier, Charles J Ferro, Thomas A Jackson, Adnan Sharif
{"title":"Somatic Symptoms of Depression Lose Association with Mortality upon Adjustment for Frailty: Analysis from the Fitness Haemodialysis Cohort.","authors":"Benjamin M Anderson,&nbsp;Muhammad Qasim,&nbsp;Gonzalo Correa,&nbsp;Felicity Evison,&nbsp;Suzy Gallier,&nbsp;Charles J Ferro,&nbsp;Thomas A Jackson,&nbsp;Adnan Sharif","doi":"10.1155/2023/4518843","DOIUrl":"https://doi.org/10.1155/2023/4518843","url":null,"abstract":"<p><strong>Introduction: </strong>The somatic symptom component of depression is associated with increased hospitalisation and mortality and poorer health-related quality of life (HRQOL). However, the relationship of subsets of depression symptoms with frailty and outcomes is not known. This study aimed to (1) explore the relationship between the Clinical Frailty Scale (CFS) and components of depression and (2) their association with mortality, hospitalisation, and HRQOL in haemodialysis recipients.</p><p><strong>Methods: </strong>We conducted a prospective cohort study of prevalent haemodialysis recipients, with deep bio-clinical phenotyping including CFS and PHQ-9 somatic (fatigue, poor appetite, and poor sleep) and cognitive component scores. EuroQol EQ-5D summary index assessed HRQOL at the baseline. Electronic linkage to English national administration datasets ensured robust follow-up data for hospitalisation and mortality events. <i>Findings</i>. Somatic (<i>β</i> = 0.067; 95% C.I. 0.029 to 0.104; <i>P</i> < 0.001) and cognitive (<i>β</i> = 0.062; 95% C.I. 0.034 to 0.089; <i>P</i><0.001) components were associated with increased CFS scores. Both somatic (<i>β</i> = -0.062; 95% C.I. -0.104 to -0.021; <i>P</i><0.001) and cognitive (<i>β</i> = 0.052; 95% C.I. -0.081 to -0.024; <i>P</i> < 0.001) scores were associated with lower HRQOL. Somatic scores lost mortality association on addition of CFS to the multivariable model (HR1.06; 95% C.I. 0.977 to 1.14; <i>P</i>=0.173). Cognitive symptoms were not associated with mortality. Neither the component score was associated with hospitalisation on multivariable analyses.</p><p><strong>Conclusions: </strong>Both somatic and cognitive depression symptoms are associated with frailty and poorer HRQOL in haemodialysis recipients but were not associated with mortality or hospitalisation when adjusted for frailty. The risk profile of depression somatic scores may be related to overlap with symptoms of frailty.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307017/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9794119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信